Edward Snowden may get Russian citizenship in coming years — lawyerWorld January 18, 15:20
Russia ready for dialog with US on Dima Yakovlev Law — top lawmakerRussian Politics & Diplomacy January 18, 14:57
Lavrov says Russia ready to cooperate with US in areas where their interests coincideRussian Politics & Diplomacy January 18, 14:50
Moscow welcomes Jaysh al-Islam group’s readiness to join talks with DamascusRussian Politics & Diplomacy January 18, 14:18
Crimea’s head invites French presidential contender Le Pen to visit peninsulaRussian Politics & Diplomacy January 18, 14:05
Lavrov says EU countries’ leaders openly interfered in US election campaignRussian Politics & Diplomacy January 18, 13:52
Russian top diplomat believes OSCE may play important role in settling Ukrainian crisisRussian Politics & Diplomacy January 18, 13:29
Iran strongly opposes US participation in Syria talks in Astana — leader’s advisorWorld January 18, 13:28
Press review: Trump terrifies Western elites and Alibaba eyes partnership with SberbankPress Review January 18, 13:00
ST. PETERSBURG, January 20. /TASS/. The US pharmaceuticals producer Pfizer will launch a joint production with St. Petersburg-based scientific and technological pharmaceutical company Polysan, a source familiar with the matter told TASS, adding that the sides are expected to sign the agreement in end-January.
"In end-January an agreement will be signed on production of Pfizer medicines in St. Petersburg and its localization. At the same time a joint production with Polysan pharm producer will be announced," the source said.
An official in St. Petersburg confirmed to TASS such an agreement is being prepared, saying that the signing is planned for January 25.
A representative of Polysan said when commenting the information that the company’s policy "is aimed at development of local pharmaceutical industry, including via cooperation with leading global pharma producers."
Polysan has manufacturing plants in St. Petersburg and Belgorod. In St. Petersburg, the company produces 4 its own brands of medicines, as well as a neurological drug within partnership with German Stada. In 2015, Polysan signed a 10-year agreement with German pharmaceuticals giant Bayer.
Polysan products are supplied to all regions in Russia, to the former CIS countries, South East Asia, Latin America and Mongolia.